Genetically Encoded Glucosensor for Multiplexed 129Xe NMR
ACS Sensors · 2026
DOI: 10.1021/acssensors.6c02887 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Jiayi He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States. Hauptthemen laut MEDLINE: Xenon Isotopes, Glucose, Monosaccharide Transport Proteins, Biosensing Techniques. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Hyperpolarized 129Xe NMR provides a non-optical platform for molecular, multiplexed detection. Genetically encoded protein reporters are attractive for biological sensing, but creating new 129Xe NMR sensors remains challenging because productive xenon binding is difficult to engineer into protein scaffolds. Here, we use glucose/galactose-binding protein (GGBP) as a ligand-responsive model protein to examine how molecular dynamics (MD)-derived cavity descriptors can guide the design of a xenon-binding protein sensor. Direct transfer of cavity-forming mutation from a related periplasmic binding protein (PBP) did not produce a well-resolved 129Xe response, motivating a broader analysis of candidate cavities by MD simulations. Among the GGBP variants examined, I24F/F90A combined an appropriate cavity volume, high pocket persistence, solvent exclusion, and high hydrophobicity density within the mutant series. The resulting glucosensor, GS, bound glucose with low-micromolar affinity and produced a distinct glucose-dependent 129Xe@GS hyper-CEST resonance shifted 30 ppm upfield from the aqueous xenon signal. This upfield resonance expands the chemical-shift window for genetically encoded protein-based 129Xe sensors to 125 ppm, highlighting an additional cavity-engineering route for modulating 129Xe NMR chemical shifts. GS enabled quantification of micromolar glucose concentrations in E. coli lysate, with results comparable to an enzymatic glucose assay. The upfield-shifted 129Xe NMR signal also allowed 129Xe@GS to be spectrally resolved from other PBP-based 129Xe sensors, enabling simultaneous detection of glucose-, ribose-, and maltose-responsive signals in a single hyper-CEST experiment. Finally, fusion of GS to the “always-on” 129Xe NMR contrast agent TEM-1 β-lactamase generated a ratiometric sensor. These results establish GGBP as a new scaffold for ligand-responsive 129Xe biosensing and introduce an MD-informed strategy for developing multiplexed and self-referenced genetically encoded 129Xe NMR sensors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
ORCID-Profile: Ivan J Dmochowski
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
He, J., Rudman, N. A., Nisita, G., & Dmochowski, I. J. (2026). Genetically Encoded Glucosensor for Multiplexed 129Xe NMR. ACS Sensors. https://doi.org/10.1021/acssensors.6c02887
Vancouver
He J, Rudman NA, Nisita G, Dmochowski IJ. Genetically Encoded Glucosensor for Multiplexed 129Xe NMR. ACS Sensors. 2026. doi:10.1021/acssensors.6c02887
BibTeX
@article{He2026,
author = {He, Jiayi and Rudman, Nathan A and Nisita, Giulia and Dmochowski, Ivan J},
title = {Genetically Encoded Glucosensor for Multiplexed 129Xe NMR},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c02887}
}
EUVIMED